FRAMING NPR Health emphasized Scientific Breakthrough; Fox News Health emphasized FDA Speed & Industry Detail.
WHAT BOTH SIDES REPORT
- ▸The approval covers the most common type of pancreatic cancer, a historically hard-to-treat disease. — NPR Health, Fox News Health
LEFT / CENTER-LEFT
- ▸The drug offers a new approach by blocking a protein that fuels tumor growth in the vast majority of cases. — NPR Health
- ▸Coverage framed the approval as a landmark scientific breakthrough for a deadly cancer. — NPR Health
RIGHT / CENTER-RIGHT
- ▸Rasonque is manufactured by Revolution Medicines in California and taken as a once-daily tablet. — Fox News Health
- ▸The FDA approved it more than six months ahead of its review deadline. — Fox News Health




